A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
about
Economic evaluations of personalized medicine: existing challenges and current developmentsReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseasePharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseThiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment responseClinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disordersTPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation.Implementation of TPMT testing.Personalized medicine policy challenges: measuring clinical utility at point of care.Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing.A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.Benefit of pre-emptive pharmacogenetic information on clinical outcome.The economic case for precision medicine.Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study.The role of endoscopy and biopsy in the management of severe gastrointestinal disease in cystic fibrosis patients
P2860
Q26797183-DD81B9D9-D9CC-4BC5-8940-B6C2D89F80BCQ26822029-63694B78-6EA3-4C1E-BD4F-9123B4E8AD7AQ28068930-7207391E-A042-4C68-AB32-00193F70AD09Q33674158-ED8F0087-1414-45DE-BF78-DDE68715A5FEQ34391577-AF25BC8D-5394-4EEE-BDB9-5E82EDC56D81Q37490046-E5EAF294-DEDC-439A-A97D-F502A8815C5EQ37678056-279DFD4D-623D-4656-A621-88AEC063FC73Q38027568-6FED4C95-B891-4F03-9BB1-BB31431742B7Q38233757-E12BB683-08C1-4695-A111-77B999E3F92FQ38563075-68B45635-75D1-4760-908B-7FF1C8EDF4D0Q38712266-AA561A3B-3EEE-48C3-852A-FD32830E3A8EQ38777644-C1ECEB94-CCCC-4B81-9F66-CECBF8CA5268Q42358509-91A0252D-68E2-4EEF-8F4D-866C62E7E0C0Q46927375-CD7B9A84-8592-486B-87E0-DD99189596F3Q49612005-372777A0-6417-403A-A238-E22D135DC521Q55217201-690FEAD5-0131-4B06-A9E3-5B9B054224E3Q55259199-1276D086-DA32-4D6C-9328-5FA4AF309DC2Q57521925-2A75C53B-9C39-4DD7-A64B-28F820691BE1
P2860
A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A pragmatic randomized control ...... e treatment: the TARGET study.
@en
A pragmatic randomized control ...... e treatment: the TARGET study.
@nl
type
label
A pragmatic randomized control ...... e treatment: the TARGET study.
@en
A pragmatic randomized control ...... e treatment: the TARGET study.
@nl
prefLabel
A pragmatic randomized control ...... e treatment: the TARGET study.
@en
A pragmatic randomized control ...... e treatment: the TARGET study.
@nl
P2093
P2860
P50
P356
P1433
P1476
A pragmatic randomized control ...... e treatment: the TARGET study.
@en
P2093
Debbie Payne
Faeiza Qasim
Gary P Sidgwick
J Brian Houston
Jon Shaffer
Karen Tricker
Marco Heise
Robert Elles
Simon C Ramsden
Sudeep Pushpakom
P2860
P304
P356
10.2217/PGS.11.32
P50
P577
2011-05-03T00:00:00Z